BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37759268)

  • 21. Is platelet transfusion associated with hospital-acquired infections in critically ill patients?
    Aubron C; Flint AW; Bailey M; Pilcher D; Cheng AC; Hegarty C; Martinelli A; Reade MC; Bellomo R; McQuilten Z
    Crit Care; 2017 Jan; 21(1):2. PubMed ID: 28057057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ABO Matching of Platelet Transfusions in Critically Ill Children.
    Nellis ME; Goel R; Karam O; Cushing MM; Davis PJ; Steiner ME; Tucci M; Stanworth SJ; Spinella PC; ;
    Pediatr Crit Care Med; 2019 Feb; 20(2):e61-e69. PubMed ID: 30422914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic platelet transfusion prior to central venous catheter placement in patients with thrombocytopenia: study protocol for a randomised controlled trial.
    van de Weerdt EK; Biemond BJ; Zeerleder SS; van Lienden KP; Binnekade JM; Vlaar APJ;
    Trials; 2018 Feb; 19(1):127. PubMed ID: 29463280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet transfusion improves clot formation and platelet function in severely thrombocytopenic haematology patients.
    Karlström C; Gryfelt G; Schmied L; Meinke S; Höglund P
    Br J Haematol; 2022 Jan; 196(1):224-233. PubMed ID: 34528253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
    Drews RE
    Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between platelet transfusions and bleeding in critically ill patients with thrombocytopenia.
    Arnold DM; Lauzier F; Albert M; Williamson D; Li N; Zarychanski R; Doig C; McIntyre L; Freitag A; Crowther M; Saunders L; Clarke F; Bellomo R; Qushmaq I; Lopes RD; Heels-Ansdell D; Webert K; Cook D;
    Res Pract Thromb Haemost; 2017 Jul; 1(1):103-111. PubMed ID: 30046678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A no-prophylaxis platelet-transfusion strategy for hematologic cancers.
    Stanworth SJ; Estcourt LJ; Powter G; Kahan BC; Dyer C; Choo L; Bakrania L; Llewelyn C; Littlewood T; Soutar R; Norfolk D; Copplestone A; Smith N; Kerr P; Jones G; Raj K; Westerman DA; Szer J; Jackson N; Bardy PG; Plews D; Lyons S; Bielby L; Wood EM; Murphy MF;
    N Engl J Med; 2013 May; 368(19):1771-80. PubMed ID: 23656642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The TREATT Trial (TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial.
    Estcourt LJ; McQuilten Z; Powter G; Dyer C; Curnow E; Wood EM; Stanworth SJ;
    Trials; 2019 Oct; 20(1):592. PubMed ID: 31615553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions.
    Anderson NA; Gray S; Copplestone JA; Chan DC; Hamon M; Prentice AG; Johnson SA; Phillips M; van Waeg G; Oakhill A; Abeyasekera S; Pamphilon DH
    Transfus Med; 1997 Mar; 7(1):33-9. PubMed ID: 9089983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombocytopenia and platelet transfusion in UK critical care: a multicenter observational study.
    Stanworth SJ; Walsh TS; Prescott RJ; Lee RJ; Watson DM; Wyncoll DL;
    Transfusion; 2013 May; 53(5):1050-8. PubMed ID: 22928908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An audit of platelet transfusion within the Wellington Cancer Centre.
    Buhrkuhl DC; Karlsson MK; Carter JM
    Intern Med J; 2012 Jan; 42(1):65-70. PubMed ID: 21040321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compliance with prophylactic platelet transfusion trigger in haematological patients.
    Eikenboom JC; van Wordragen R; Brand A
    Transfus Med; 2005 Feb; 15(1):45-8. PubMed ID: 15713128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.
    Akkök CA; Brinch L; Lauritzsen GF; Solheim BG; Kjeldsen-Kragh J
    Vox Sang; 2007 Jul; 93(1):42-8. PubMed ID: 17547564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
    Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
    Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect and duration of prophylactic platelet transfusions before insertion of a central venous catheter in patients with bone marrow failure evaluated with point-of-care methods and flow cytometry.
    Kander T; Tanaka KA; Norström E; Persson J; Schött U
    Anesth Analg; 2014 Oct; 119(4):882-890. PubMed ID: 24854870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial.
    Lye DC; Archuleta S; Syed-Omar SF; Low JG; Oh HM; Wei Y; Fisher D; Ponnampalavanar SSL; Wijaya L; Lee LK; Ooi EE; Kamarulzaman A; Lum LC; Tambyah PA; Leo YS
    Lancet; 2017 Apr; 389(10079):1611-1618. PubMed ID: 28283286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy.
    Callow CR; Swindell R; Randall W; Chopra R
    Br J Haematol; 2002 Aug; 118(2):677-82. PubMed ID: 12139764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia.
    Vinholt PJ; Alnor A; Nybo M; Hvas AM
    Platelets; 2016 Sep; 27(6):547-54. PubMed ID: 27025360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet Transfusions in the PICU: Does Disease Severity Matter?
    Saini A; West AN; Harrell C; Jones TL; Nellis ME; Joshi AD; Cowan KM; Gatewood CW; Ryder AB; Reiss UM
    Pediatr Crit Care Med; 2018 Sep; 19(9):e472-e478. PubMed ID: 29927877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.